SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,413 | +32.9% | 41,300 | -50.0% | 0.00% | – |
| Q4 2022 | $28,910 | +37.7% | 82,600 | +100.0% | 0.00% | – |
| Q3 2022 | $21,000 | -65.6% | 41,300 | -44.0% | 0.00% | – |
| Q2 2022 | $61,000 | -87.4% | 73,800 | -77.7% | 0.00% | – |
| Q1 2022 | $486,000 | -32.5% | 330,471 | +26.7% | 0.00% | – |
| Q4 2021 | $720,000 | -43.8% | 260,809 | +15.0% | 0.00% | – |
| Q3 2021 | $1,281,000 | -7.0% | 226,721 | +76.5% | 0.00% | – |
| Q2 2021 | $1,378,000 | -19.2% | 128,428 | +68.2% | 0.00% | – |
| Q1 2021 | $1,706,000 | – | 76,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|